Vancomycin-resistant enterococcal infections.
Murray
B E
BE
Department of Medicine, and Center for the Study of Emerging and Re-Emerging Pathogens, University of Texas Medical School, Houston 77030, USA. infdis@heart.med.uth.tmc.edu
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D015169:Colony Count, Microbial; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D016983:Enterococcus / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D024841:Fluoroquinolones; D006020:Glycopeptides; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007769:Lactams; D020713:Vancomycin Resistance / Q000235:genetics
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D006020:Glycopeptides; D007769:Lactams